Kevin E. Bove
Impact in
- Clinical Biochemistry top 0.5%
- Metabolism and Genetic Disorders
- Surgery top 1%
- Pediatric Hepatobiliary Diseases and Treatments
- Congenital Anomalies and Fetal Surgery
Papers in
-
- Metabolism and Genetic Disorders 22
- Genetics 21
- Neurogenetic and Muscular Disorders Research 11
- Co-authors
- James E. HeubiWilliam F. BalistreriYuri E. NikiforovKenneth D.R. SetchellJ. Mark RowlandJames A. FaginRonald J. SokolSusan T. Iannaccone
- Journals
- Pediatric and Developmental Pathology (15 papers)The Journal of Pediatrics (15 papers)New England Journal of Medicine (6 papers)Human Pathology (6 papers)The American Journal of Surgical Pathology (6 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Kevin E. Bove
208 papers receiving 7.9k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Clinical Biochemistry 624
- Surgery 2.5k
- Pulmonary and Respiratory Medicine 1.5k
- Oncology 1.2k
- Rheumatology 613
Countries citing papers authored by Kevin E. Bove
This map shows the geographic impact of Kevin E. Bove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin E. Bove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin E. Bove more than expected).
Fields of papers citing papers by Kevin E. Bove
This network shows the impact of papers produced by Kevin E. Bove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin E. Bove. The network helps show where Kevin E. Bove may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kevin E. Bove, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2022 | 4 | |
| 3 | 2019 | 24 | |
| 4 | 2018 | 14 | |
| 5 | 2018 | 11 | |
| 6 | 2017 | 39 | |
| 7 | 2013 | 20 | |
| 8 | 2009 | 10 | |
| 9 | 2004 | 62 | |
| 10 | Nucleophosmin/B23 Is a Target of CDK2/Cyclin E in Centrosome Duplication Hit paper breakdown → | 2000 | 546 |
| 11 | 1991 | 61 | |
| 12 | 1991 | 7 | |
| 13 | 1989 | 33 | |
| 14 | 1988 | 3 | |
| 15 | Lessons from the E-Ferol tragedy. | 1986 | 30 |
| 16 | 1983 | 45 | |
| 17 | 1977 | 7 | |
| 18 | 1976 | 20 | |
| 19 | 1975 | 1 | |
| 20 | 1972 | 2 |
About Kevin E. Bove
Kevin E. Bove is a scholar working on Clinical Biochemistry, Genetics, Surgery, Pulmonary and Respiratory Medicine and Urology, having authored 215 papers that have together received 8.3k indexed citations. Recurring topics across this work include Pediatric Hepatobiliary Diseases and Treatments (29 papers), Metabolism and Genetic Disorders (22 papers), Drug Transport and Resistance Mechanisms (15 papers), Congenital Anomalies and Fetal Surgery (14 papers), Mitochondrial Function and Pathology (14 papers), Renal and related cancers (11 papers), Neurogenetic and Muscular Disorders Research (11 papers) and Gallbladder and Bile Duct Disorders (10 papers). The work is most often cited by research in Clinical Biochemistry (624 citations), Surgery (2.5k citations), Pulmonary and Respiratory Medicine (1.5k citations), Oncology (1.2k citations) and Rheumatology (613 citations). Kevin E. Bove has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include James E. Heubi, William F. Balistreri, Yuri E. Nikiforov, Kenneth D.R. Setchell, J. Mark Rowland, James A. Fagin, Ronald J. Sokol, Susan T. Iannaccone, A. James McAdams and Ralph C. Scott. Their work appears in journals such as Pediatric and Developmental Pathology, The Journal of Pediatrics, New England Journal of Medicine, Human Pathology and The American Journal of Surgical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.